The Effects of Levosimendan on Microcirculation and Peripheral Perfusion in Septic Shock: A Pilot Study

Septic patients can show multiorgan failure even after an apparent recovery of hemodynamic stability. The underlying mechanism is unclear, but the main pathological element is microcirculation impairment, leading to insufficient oxygen delivery. This study aimed to assess the effects of levosimendan...

Full description

Saved in:
Bibliographic Details
Main Authors: Veronica Gagliardi, Francesco Ceccherelli, Antonello Lovato, Giuseppe Gagliardi
Format: Article
Language:English
Published: MDPI AG 2025-05-01
Series:Life
Subjects:
Online Access:https://www.mdpi.com/2075-1729/15/6/871
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849432452205903872
author Veronica Gagliardi
Francesco Ceccherelli
Antonello Lovato
Giuseppe Gagliardi
author_facet Veronica Gagliardi
Francesco Ceccherelli
Antonello Lovato
Giuseppe Gagliardi
author_sort Veronica Gagliardi
collection DOAJ
description Septic patients can show multiorgan failure even after an apparent recovery of hemodynamic stability. The underlying mechanism is unclear, but the main pathological element is microcirculation impairment, leading to insufficient oxygen delivery. This study aimed to assess the effects of levosimendan administration on peripheral perfusion in the prodromic phases of sepsis and compare them with the variations in microcirculation perfusion occurring with conventional dobutamine therapy. Sixteen patients with sepsis were enrolled, eight of whom were treated with norepinephrine and levosimendan and the other eight with norepinephrine and dobutamine. We observed a trend of reduction in the hematic lactate concentration and an increase in peripheral perfusion in the patients treated with levosimendan. The latter also occurred in the dobutamine group, although to a lower degree. Hematic lactate was significantly reduced in the levosimendan group, probably because of the enhanced aerobic metabolism, due to both the action on mitochondrial K<sub>ATP</sub> channels and the better oxygen delivery to cells. The lactate values varied from T<sub>0</sub> (2.28 ± 0.25 mmol/L) to T<sub>2</sub> (1.45 ± 0.31 mmol/L) in the levosimendan group vs. from T<sub>0</sub> (2.79 ± 0.91 mmol/L) to T<sub>2</sub> (2.92 ± 0.76 mmol/) L in the dobutamine group. Hence, levosimendan may be indicated in septic patients with impaired microcirculation and tissue oxygenation and, consequently, high lactate levels. Further studies are needed to draw a profile of levosimendan as a possible treatment to restore microcirculation in septic patients.
format Article
id doaj-art-d815581be5b04c6599072ec452c7301b
institution Kabale University
issn 2075-1729
language English
publishDate 2025-05-01
publisher MDPI AG
record_format Article
series Life
spelling doaj-art-d815581be5b04c6599072ec452c7301b2025-08-20T03:27:21ZengMDPI AGLife2075-17292025-05-0115687110.3390/life15060871The Effects of Levosimendan on Microcirculation and Peripheral Perfusion in Septic Shock: A Pilot StudyVeronica Gagliardi0Francesco Ceccherelli1Antonello Lovato2Giuseppe Gagliardi3Department of Anesthesiology and Intensive Care, University of Padova, 35122 Padova, ItalyAIRAS, 36045 Lonigo, ItalyAIRAS, 36045 Lonigo, ItalyDepartment of Anesthesiology and Intensive Care, University of Padova, 35122 Padova, ItalySeptic patients can show multiorgan failure even after an apparent recovery of hemodynamic stability. The underlying mechanism is unclear, but the main pathological element is microcirculation impairment, leading to insufficient oxygen delivery. This study aimed to assess the effects of levosimendan administration on peripheral perfusion in the prodromic phases of sepsis and compare them with the variations in microcirculation perfusion occurring with conventional dobutamine therapy. Sixteen patients with sepsis were enrolled, eight of whom were treated with norepinephrine and levosimendan and the other eight with norepinephrine and dobutamine. We observed a trend of reduction in the hematic lactate concentration and an increase in peripheral perfusion in the patients treated with levosimendan. The latter also occurred in the dobutamine group, although to a lower degree. Hematic lactate was significantly reduced in the levosimendan group, probably because of the enhanced aerobic metabolism, due to both the action on mitochondrial K<sub>ATP</sub> channels and the better oxygen delivery to cells. The lactate values varied from T<sub>0</sub> (2.28 ± 0.25 mmol/L) to T<sub>2</sub> (1.45 ± 0.31 mmol/L) in the levosimendan group vs. from T<sub>0</sub> (2.79 ± 0.91 mmol/L) to T<sub>2</sub> (2.92 ± 0.76 mmol/) L in the dobutamine group. Hence, levosimendan may be indicated in septic patients with impaired microcirculation and tissue oxygenation and, consequently, high lactate levels. Further studies are needed to draw a profile of levosimendan as a possible treatment to restore microcirculation in septic patients.https://www.mdpi.com/2075-1729/15/6/871microcirculationinodilatorslevosimendanseptic shock
spellingShingle Veronica Gagliardi
Francesco Ceccherelli
Antonello Lovato
Giuseppe Gagliardi
The Effects of Levosimendan on Microcirculation and Peripheral Perfusion in Septic Shock: A Pilot Study
Life
microcirculation
inodilators
levosimendan
septic shock
title The Effects of Levosimendan on Microcirculation and Peripheral Perfusion in Septic Shock: A Pilot Study
title_full The Effects of Levosimendan on Microcirculation and Peripheral Perfusion in Septic Shock: A Pilot Study
title_fullStr The Effects of Levosimendan on Microcirculation and Peripheral Perfusion in Septic Shock: A Pilot Study
title_full_unstemmed The Effects of Levosimendan on Microcirculation and Peripheral Perfusion in Septic Shock: A Pilot Study
title_short The Effects of Levosimendan on Microcirculation and Peripheral Perfusion in Septic Shock: A Pilot Study
title_sort effects of levosimendan on microcirculation and peripheral perfusion in septic shock a pilot study
topic microcirculation
inodilators
levosimendan
septic shock
url https://www.mdpi.com/2075-1729/15/6/871
work_keys_str_mv AT veronicagagliardi theeffectsoflevosimendanonmicrocirculationandperipheralperfusioninsepticshockapilotstudy
AT francescoceccherelli theeffectsoflevosimendanonmicrocirculationandperipheralperfusioninsepticshockapilotstudy
AT antonellolovato theeffectsoflevosimendanonmicrocirculationandperipheralperfusioninsepticshockapilotstudy
AT giuseppegagliardi theeffectsoflevosimendanonmicrocirculationandperipheralperfusioninsepticshockapilotstudy
AT veronicagagliardi effectsoflevosimendanonmicrocirculationandperipheralperfusioninsepticshockapilotstudy
AT francescoceccherelli effectsoflevosimendanonmicrocirculationandperipheralperfusioninsepticshockapilotstudy
AT antonellolovato effectsoflevosimendanonmicrocirculationandperipheralperfusioninsepticshockapilotstudy
AT giuseppegagliardi effectsoflevosimendanonmicrocirculationandperipheralperfusioninsepticshockapilotstudy